IMO32 Antibody

What is IMO32 protein and why is it relevant to study?

IMO32 (YGR031W) is a mitochondrial protein in Saccharomyces cerevisiae that functions as a probable alcohol acetyltransferase. It utilizes acetyl-CoA to synthesize acetate esters from alcohols. The protein is notable for being an intermediate cleaved by mitochondrial octapeptidyl aminopeptidase (Oct1p). IMO32 is not involved in ethyl acetate synthesis, which distinguishes it from other ester-producing enzymes in yeast. Studying IMO32 contributes to our understanding of mitochondrial processing and specific enzymatic pathways involved in ester biosynthesis.

What are the key characteristics of IMO32 antibody?

The IMO32 antibody specifically binds to the IMO32 (YGR031W) protein in Saccharomyces cerevisiae. It is supplied in liquid form, preserved in 0.03% Proclin 300, and formulated in 50% glycerol with 0.01M Phosphate Buffered Saline (PBS) at pH 7.4. The antibody recognizes linear epitopes conserved across IMO32 isoforms and can detect endogenous IMO32 expression in yeast lysates. Its specificity allows for accurate detection of IMO32 protein in various experimental contexts including western blotting and immunohistochemistry applications.

What is the subcellular localization of the IMO32 protein?

IMO32 protein is primarily localized to the mitochondrion in Saccharomyces cerevisiae. This localization is consistent with its role in mitochondrial processes and its identification as an intermediate cleaved by mitochondrial octapeptidyl aminopeptidase (Oct1p). The IMO32 antibody can be used in immunohistochemistry applications to validate this mitochondrial localization, which is crucial for understanding the protein's function within cellular compartments.

Are there homologs of IMO32 in other organisms?

Yes, IMO32 has homologs across various species. The human homolog is ABHD11 (alpha/beta hydrolase domain-containing protein 11) . Other homologs include:

• Pan troglodytes (chimpanzee): ABHD11

• Canis lupus familiaris (dog): ABHD11

• Bos taurus (cattle): ABHD11

• Mus musculus (house mouse): Abhd11

• Rattus norvegicus (Norway rat): Abhd11

• Gallus gallus (chicken): ABHD11

• Danio rerio (zebrafish): abhd11

• And several fungal species including Eremothecium gossypii, Kluyveromyces lactis, and Schizosaccharomyces pombe

This evolutionary conservation suggests functional importance across diverse taxonomic groups.

How can I optimize IMO32 antibody performance in Western blotting for low-abundance samples?

For detecting low-abundance IMO32 in yeast samples, consider the following methodological approach:

• Sample preparation optimization:

  • Enrich for mitochondrial fractions using differential centrifugation

  • Use protease inhibitor cocktails containing specific inhibitors for mitochondrial proteases

  • Employ gentle lysis conditions to preserve protein integrity

• Western blotting enhancement:

  • Increase sample loading (50-100 μg total protein)

  • Use PVDF membranes (0.2 μm pore size) for better protein retention

  • Extend primary antibody incubation to overnight at 4°C

  • Employ signal enhancement systems like biotin-streptavidin amplification

  • Use highly sensitive chemiluminescent substrates

• Controls:

  • Include positive controls from yeast strains overexpressing IMO32

  • Use imo32Δ mutant samples as negative controls

  • Validate specificity with peptide competition assays

This approach has been shown to improve detection sensitivity by up to 5-fold compared to standard protocols when working with mitochondrial proteins.

What is the best approach to distinguish between different processing forms of IMO32?

IMO32 is processed by mitochondrial octapeptidyl aminopeptidase (Oct1p), resulting in different intermediate forms. To distinguish between these processing variants:

• Gel system optimization:

  • Use modified Laemmli buffer systems with 8M urea

  • Employ gradient gels (10-20%) for better resolution of closely migrating bands

  • Consider using Phos-tag™ gels if phosphorylation affects processing

• Two-dimensional electrophoresis:

  • First dimension: isoelectric focusing (pH 5-8 range)

  • Second dimension: SDS-PAGE

  • This approach can separate processing intermediates based on both size and charge

• Immunoprecipitation coupled with mass spectrometry:

  • Use the IMO32 antibody to pull down all forms

  • Analyze by LC-MS/MS to identify specific cleavage sites

  • Quantify relative abundance of each processing intermediate

• Time-course studies:

  • Block protein synthesis with cycloheximide

  • Monitor processing over time with the IMO32 antibody

  • Include Oct1p inhibition studies to confirm processing pathway

These approaches can reveal functional differences between processing intermediates and provide insights into mitochondrial protein maturation dynamics.

How can I assess the in vivo acetyltransferase activity of IMO32 using immunological methods?

To investigate IMO32's enzymatic function as an alcohol acetyltransferase using the IMO32 antibody:

• Activity-dependent labeling:

  • Design activity-based probes that covalently modify active IMO32

  • Combine with IMO32 antibody detection to quantify active versus total enzyme

  • Compare wild-type and catalytic mutants to validate specificity

• Proximity ligation assay (PLA):

  • Use IMO32 antibody in combination with antibodies against acetyl-CoA carriers

  • PLA signal indicates proximity/interaction between enzyme and substrate carrier

  • Quantify signal changes under different metabolic conditions

• Immunoprecipitation followed by activity assay:

  • Pull down IMO32 using the antibody

  • Perform in vitro acetyltransferase assays with the immunoprecipitated material

  • Measure acetate ester formation by gas chromatography-mass spectrometry

• Correlative microscopy:

  • Combine immunofluorescence using IMO32 antibody with metabolite imaging

  • Assess colocalization of enzyme with substrate and product pools

  • Perform in strains with varied ester production capabilities

This multi-method approach provides complementary data on enzyme activity, substrate accessibility, and product formation in physiologically relevant contexts.

What are the considerations for using IMO32 antibody in cross-species studies?

When applying the IMO32 antibody to study homologs in different species:

• Epitope conservation analysis:

  • Perform sequence alignment of IMO32 homologs across target species

  • Identify regions of high conservation that may contain the antibody epitope

  • Predict cross-reactivity based on epitope conservation scores

• Validation strategy:

  • Test against recombinant homolog proteins (e.g., human ABHD11)

  • Include knockout/knockdown controls for each species

  • Perform peptide competition assays with species-specific peptides

• Signal interpretation:

  • Expect potentially different banding patterns based on species-specific processing

  • Adjust experimental conditions (buffer composition, incubation times) for each species

  • Quantify relative affinity differences using titration experiments

• Complementary approaches:

  • Use epitope-tagged versions of homologs when antibody cross-reactivity is suboptimal

  • Develop species-specific antibodies targeting highly conserved functional domains

  • Consider using multiple antibodies targeting different epitopes for validation

This systematic approach minimizes misinterpretation when studying IMO32 homologs across evolutionary distant species.

What are the optimal conditions for immunoprecipitation using IMO32 antibody?

For effective immunoprecipitation of IMO32 from yeast extracts:

• Lysis buffer composition:

  • Base buffer: 20 mM HEPES-KOH (pH 7.4), 150 mM KCl

  • Detergents: 0.5% Triton X-100 or 1% digitonin (to preserve mitochondrial protein complexes)

  • Protease inhibitors: Complete Mini EDTA-free cocktail supplemented with 1 mM PMSF

  • Phosphatase inhibitors: 10 mM NaF, 1 mM Na₃VO₄

  • Reducing agent: 1 mM DTT (freshly added)

• Antibody coupling:

  • Pre-couple 5 μg IMO32 antibody to 50 μl Protein G magnetic beads

  • Cross-link using BS³ or DMP for minimal antibody leaching

  • Prepare parallel control beads with non-specific IgG

• Immunoprecipitation protocol:

  • Pre-clear lysate (1 mg protein) with control beads for 1 hour at 4°C

  • Incubate with antibody-coupled beads overnight at 4°C with gentle rotation

  • Wash 4 times with lysis buffer containing reduced detergent (0.1%)

  • Perform specific elution with competing peptide or general elution with SDS sample buffer

• Verification steps:

  • Analyze 5% of input, unbound, and eluted fractions

  • Confirm specific precipitation using Western blotting

  • Assess co-precipitating partners by mass spectrometry

This protocol maintains native protein interactions while minimizing background contamination.

How can I develop a quantitative ELISA using IMO32 antibody?

To establish a quantitative ELISA for measuring IMO32 levels:

• Assay format selection:

  • Sandwich ELISA: Requires two antibodies recognizing different epitopes (use IMO32 antibody as capture or detection)

  • Competitive ELISA: Better for small proteins or specific epitope detection

  • Direct ELISA: Simplest approach but may have higher background

• Optimization parameters:

  • Coating concentration: Titrate between 1-10 μg/ml for capture antibody

  • Blocking solution: 3% BSA in PBS-T (PBS with 0.05% Tween-20)

  • Sample preparation: Include detergent-compatible lysis buffer

  • Detection antibody dilution: Test range from 1:500 to 1:5000

  • Substrate selection: TMB for colorimetric or luminol for chemiluminescent detection

• Standard curve preparation:

  • Use purified recombinant IMO32 at 0.1-100 ng/ml

  • Include matrix-matched calibrators

  • Employ four-parameter logistic regression for curve fitting

• Validation metrics:

  • Limit of detection: Typically 0.1-0.5 ng/ml for optimized assays

  • Precision: CV < 10% for intra-assay, < 15% for inter-assay

  • Recovery: 80-120% spiking recovery in complex matrices

  • Linearity: R² > 0.98 across the working range

This approach provides a robust quantitative method for IMO32 measurement in research samples.

What fixation and permeabilization methods work best for IMO32 immunohistochemistry?

For optimal IMO32 detection in yeast cells and tissues:

• Fixation protocols:

  • Chemical fixation: 4% paraformaldehyde for 20 minutes preserves epitope accessibility

  • Combined approach: 2% paraformaldehyde + 0.2% glutaraldehyde for 15 minutes balances structure preservation and antibody penetration

  • Methanol fixation (-20°C, 5 minutes) for simultaneous fixation and permeabilization

• Permeabilization strategies:

  • Yeast cell wall removal: Enzymatic digestion with 20 mg/ml Zymolyase-20T for 30 minutes

  • Membrane permeabilization: 0.2% Triton X-100 for 10 minutes or 0.1% saponin throughout all steps

  • Antigen retrieval: 10 mM sodium citrate buffer (pH 6.0) at 95°C for 10 minutes for improved epitope accessibility

• Blocking conditions:

  • 5% normal goat serum + 2% BSA in PBS for 1 hour at room temperature

  • Include 0.1% Tween-20 throughout washing and antibody incubation steps

  • Add 0.1% glycine to quench free aldehyde groups after aldehyde fixation

• Antibody application:

  • Optimal dilution: 1:100 to 1:500 (determine empirically)

  • Incubation time: Overnight at 4°C for best signal-to-noise ratio

  • Secondary antibody: Fluorophore-conjugated anti-species antibodies at 1:500

These optimized methods ensure specific labeling while preserving mitochondrial morphology.

How can I resolve nonspecific binding issues with IMO32 antibody?

When encountering nonspecific binding:

• Antibody validation steps:

  • Confirm specificity using imo32Δ knockout controls

  • Perform peptide competition assays to identify specific bands

  • Test multiple antibody lots if available

• Protocol modifications:

  • Increase blocking stringency: 5% BSA + 5% normal serum from secondary antibody species

  • Add 0.1-0.5% nonfat dry milk to antibody dilution buffer

  • Incorporate 100-200 mM NaCl in washing buffer to disrupt low-affinity interactions

  • Decrease primary antibody concentration (use titration series)

• Sample preparation adjustments:

  • Add carrier proteins (0.1-0.5% BSA) to diluted antibody solutions

  • Pre-absorb antibody against acetone powder from imo32Δ yeast

  • Use stronger detergents (0.1% SDS) in washing steps for Western blots

  • Increase number and duration of washes

• Buffer optimization:

  • Test different pH conditions (pH 7.0-8.0)

  • Add mild protein denaturants like 0.5-1M urea to reduce hydrophobic interactions

  • Include 5-10% polyethylene glycol to reduce nonspecific binding

These strategies can significantly improve signal-to-noise ratio for challenging samples.

What are the best methods to validate IMO32 antibody specificity?

To comprehensively validate IMO32 antibody specificity:

• Genetic validation:

  • Compare wild-type and imo32Δ deletion mutant samples

  • Test antibody against IMO32 overexpression strains

  • Examine signal in strains with tagged IMO32 (confirm co-localization)

• Biochemical validation:

  • Perform peptide competition assays using the immunizing peptide

  • Test cross-reactivity with recombinant homologs (like human ABHD11)

  • Analyze by mass spectrometry proteins recognized by the antibody

• Orthogonal methods:

  • Compare localization patterns using GFP-tagged IMO32

  • Correlate antibody signal with RNA expression levels across strains

  • Confirm expected molecular weight shifts with differently processed forms

• Analytical validation:

  • Assess lot-to-lot consistency with standard samples

  • Determine dynamic range using titration of recombinant protein

  • Test for interference from common sample components

How can I preserve IMO32 antibody activity during long-term storage?

For optimal antibody stability and performance over time:

• Storage conditions:

  • Primary storage: Aliquot and maintain at -80°C for long-term stability

  • Working stock: -20°C in 50% glycerol (as supplied)

  • Avoid repeated freeze-thaw cycles (limit to <5)

  • Protect from light if conjugated to fluorophores

• Buffer considerations:

  • Maintain preservative (0.03% Proclin 300)

  • Keep pH stable (pH 7.4 phosphate buffer)

  • Include carrier proteins (0.1% BSA) for diluted working solutions

  • Avoid oxidizing conditions

• Stability monitoring:

  • Set up an internal reference sample for periodic testing

  • Document signal intensity and background over time

  • Monitor specificity using consistent positive controls

  • Establish minimum acceptance criteria for experimental use

• Handling recommendations:

  • Use sterile technique when preparing aliquots

  • Minimize time at room temperature during experiments

  • Centrifuge briefly before opening to collect condensation

  • Consider adding stabilizing compounds (e.g., trehalose) for problematic lots

Following these practices can extend antibody shelf-life to >2 years while maintaining consistent performance.

How can IMO32 antibody be utilized in studying mitochondrial protein import and processing?

IMO32 is processed by mitochondrial octapeptidyl aminopeptidase (Oct1p), making it valuable for mitochondrial protein processing studies:

• Processing pathway analysis:

  • Use pulse-chase experiments with immunoprecipitation (IP) using IMO32 antibody

  • Detect processing intermediates in wild-type vs. oct1Δ mutants

  • Identify additional processing factors by screening processing patterns in mitochondrial protease mutants

• Import kinetics assessment:

  • Track newly synthesized IMO32 movement into mitochondria over time

  • Combine subcellular fractionation with IMO32 antibody detection

  • Quantify import efficiency under various cellular stress conditions

• Processing site mapping:

  • Immunopurify IMO32 processing intermediates using the antibody

  • Analyze N-terminal sequences by Edman degradation or mass spectrometry

  • Generate processing site mutants and monitor effects with the antibody

• Conditional regulation studies:

  • Apply IMO32 antibody in time-course experiments under varied metabolic conditions

  • Correlate processing efficiency with enzymatic activity

  • Detect changes in import/processing during cellular aging or stress response

This approach provides insights into fundamental mitochondrial protein maturation pathways while using IMO32 as a model substrate.

What approaches can be used to study IMO32 protein-protein interactions?

To investigate the interactome of IMO32:

• Co-immunoprecipitation methods:

  • Use IMO32 antibody for pull-down under native conditions

  • Employ crosslinking (DSP, formaldehyde) to capture transient interactions

  • Analyze precipitated complexes by mass spectrometry

  • Validate key interactions with reciprocal co-IPs

• Proximity labeling techniques:

  • Generate BioID or APEX2 fusions with IMO32

  • Compare biotinylated proteins with IMO32 antibody co-IP results

  • Classify interactions as stable or transient based on method consistency

  • Map interaction domains through truncation analyses

• In situ approaches:

  • Perform proximity ligation assays (PLA) between IMO32 and suspected partners

  • Use IMO32 antibody with FRET-based interaction sensors

  • Implement FLIM-FRET to quantify interaction strength in living cells

  • Correlate interaction dynamics with metabolic state

• Structural studies:

  • Immunopurify native complexes for cryo-EM analysis

  • Combine with hydrogen-deuterium exchange mass spectrometry (HDX-MS)

  • Map interaction surfaces using crosslinking mass spectrometry (XL-MS)

  • Validate structural predictions with site-directed mutagenesis

These complementary approaches establish the functional interaction network around IMO32 within mitochondria.

How can IMO32 antibody contribute to understanding the role of this protein in mitochondrial function?

To investigate IMO32's role in mitochondrial biology:

• Functional proteomics approach:

  • Compare mitochondrial proteomes from wild-type and imo32Δ strains

  • Use IMO32 antibody to confirm differential regulation of key proteins

  • Correlate proteome changes with alterations in mitochondrial function

  • Identify compensatory mechanisms in knockout strains

• Metabolic analysis:

  • Measure acetate ester production in wild-type vs. imo32Δ mutants

  • Correlate IMO32 protein levels (via antibody) with metabolite profiles

  • Assess metabolic adaptation to varied carbon sources and IMO32 expression

  • Map metabolic flux changes using stable isotope labeling

• Mitochondrial dynamics assessment:

  • Monitor mitochondrial morphology changes in relation to IMO32 expression

  • Use the antibody to track IMO32 distribution during fission/fusion events

  • Investigate IMO32 levels during mitophagy and quality control processes

  • Examine IMO32 expression during mitochondrial stress responses

• Evolutionary conservation studies:

  • Compare IMO32 function with homologs (like human ABHD11)

  • Test cross-reactivity with homologs in diverse species

  • Identify conserved vs. species-specific functions using complementation assays

  • Correlate expression patterns across evolutionarily diverse organisms

This multifaceted approach provides comprehensive insights into IMO32's contribution to mitochondrial function and cellular metabolism.

How is IMO32 antibody being applied in emerging research areas?

Recent applications of IMO32 antibody in cutting-edge research include:

• Systems biology integration:

  • Multi-omics studies correlating IMO32 levels with transcriptome and metabolome data

  • Network analysis placing IMO32 in mitochondrial functional modules

  • Identification of condition-specific regulation patterns across varied environments

  • Development of predictive models for ester production based on IMO32 expression

• Mitochondrial disease models:

  • Investigation of IMO32 homologs (ABHD11) in human mitochondrial disorders

  • Use of yeast IMO32 as a model system for understanding conserved mitochondrial processes

  • Correlation of expression patterns with disease phenotypes

  • Drug screening using IMO32-based readouts for mitochondrial function

• Biotechnology applications:

  • Engineering IMO32 expression to modulate yeast flavor profiles in fermentation

  • Development of biosensors using IMO32 antibody for monitoring fermentation processes

  • Creation of synthetic pathways incorporating IMO32's acetyltransferase activity

  • Metabolic engineering strategies targeting ester biosynthesis pathways

• Advanced imaging techniques:

  • Super-resolution microscopy of IMO32 localization within mitochondrial subdomains

  • Live-cell tracking of IMO32 dynamics during cell division and stress response

  • Correlative light and electron microscopy for ultrastructural localization

  • Expansion microscopy applications for mitochondrial protein organization

These emerging applications demonstrate the versatility of IMO32 antibody as a research tool across multiple disciplines.

What methodological advances are improving IMO32 detection and analysis?

Recent technological developments enhancing IMO32 research include:

• Advanced antibody formats:

  • Single-domain antibodies (nanobodies) against IMO32 for improved penetration

  • Recombinant antibody fragments with enhanced specificity

  • Site-specific conjugation strategies for optimal orientation

  • Bispecific antibodies targeting IMO32 and interacting partners simultaneously

• High-sensitivity detection methods:

  • Single-molecule detection using antibody-conjugated quantum dots

  • Microfluidic antibody arrays for rapid protein quantification

  • Digital ELISA platforms with sub-picogram sensitivity

  • Lateral flow immunoassays for rapid field screening

• Automated analysis pipelines:

  • Machine learning algorithms for processing immunofluorescence data

  • Automated western blot analysis with standardized quantification

  • High-content screening platforms using IMO32 antibody staining

  • Integrated data analysis frameworks combining multiple antibody-based readouts

• Novel application strategies:

  • Antibody-based proximity sensors for real-time interaction monitoring

  • Intrabody applications for tracking IMO32 in living cells

  • Combined CRISPR-editing with antibody detection for function validation

  • Optogenetic tools coupled with antibody-based detection methods

These methodological advances significantly expand the research applications and sensitivity of IMO32 antibody-based techniques.